OP0213 SEX DIFFERENCES IN MULTIMORBIDITY BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS AND COMPARATORS IN A LARGE NATIONWIDE US STUDY

Abstract

Background:Patients with rheumatoid arthritis (RA) have an increased burden of multimorbidity. Although many comorbidities vary by sex, sex differences in multimorbidity among individuals with RA have not been examined.Objectives:We aimed to compare multimorbidity between women and men with RA and comparators without RA.Methods:We used a large longitudinal, real-world data warehouse with de-identified administrative claims for commercial and Medicare Advantage enrollees, to identify cases of RA and matched controls. Cases were defined as patients aged ≥18 years with ≥2 diagnoses of RA in January 1, 2010 - June 30, 2019 and ≥1 prescription fill for methotrexate in the year after the first RA diagnosis. Controls were persons without RA matched 1:1 to RA cases on age, sex, census region, calendar year of index date (corresponding to the date of second diagnosis code for RA), and length of prior medical/pharmacy coverage. Race was classified as non-Hispanic White (White), non-Hispanic Black (Black), Asian, Hispanic, or other/unknown, based on self-report or derived rule sets. Multimorbidity (2 or more comorbidities) was defined using 25 chronic comorbidities from a combination of the Charlson and Elixhauser Comorbidity Indices assessed during the year prior to index date. Rheumatic comorbidities were not included. Logistic regression models were used to estimate odds ratios (OR) with 95% confidence intervals (CI).Results:The study included 16,363 cases with RA and 16,363 matched non-RA comparators (mean age 58.2 years, 70.7% female for both cohorts). In both cohorts, women were slightly younger (mean age 57.5 vs. 59.8 years). Among RA patients, women were more racially/ethnically diverse than men, with 72% of women (78% men) being White, 12% (10%) Hispanic, 11% (7%) Black, 3% (3%) Asian, and 3% (3%) other/unknown. Racial/ethnic diversity was similar among non-RA women and men with 74% women (75% men) being White, 9% (9%) Hispanic, 10% (8%) Black, 4% (4%) Asian, and 3% (4%) other/unknown. Patients with RA had more multimorbidity than non-RA subjects (51.3% vs 44.8%). Observed rates of multimorbidity were similar in women and men with RA (51.6% vs 50.5%, p=0.18), but among non-RA patients, women had lower observed rates of multimorbidity than men (43.7% vs 47.4%, p<0.0001). However, following adjustment for age, race/ethnicity, and geographic region, multimorbidity among RA patients was greater in women versus men (OR: 1.19; 95% CI: 1.11-1.28) and similar among non-RA women and men (OR: 0.97 for females; 95% CI: 0.90-1.05). Examination of individual comorbidities showed that women with RA had more depression, hypothyroidism, diabetes mellitus, and chronic pulmonary disease compared to men with RA and women without RA.Conclusion:This large nationwide study showed increased occurrence of multimorbidity in women with RA compared to men with RA, while women and men without RA had similar levels of multimorbidity following adjustment for age, race/ethnicity, and geographic region. The underlying mechanisms for these sex differences require further investigation.Disclosure of Interests:Hayley J. Dykhoff: None declared, Elena Myasoedova: None declared, Madeline Peterson: None declared, John M Davis III Grant/research support from: Research grant from Pfizer, Vanessa Kronzer: None declared, Caitrin Coffey: None declared, Tina Gunderson: None declared, Cynthia S. Crowson: None declared